...
首页> 外文期刊>Cancer chemotherapy and pharmacology. >Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients
【24h】

Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients

机译:ANLN的过度表达有助于乳腺癌患者中蒽环类化疗的预后不良

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To investigate the associations of ANLN expression with prognosis of breast cancer and clinical outcome of anthracycline-based chemotherapy.
机译:探讨ANLN表达与乳腺癌预后及蒽环类化疗临床疗效的关系。

著录项

  • 来源
  • 作者单位

    Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;

    Hunan Prov Clin Meditech Res Ctr Breast Canc Changsha 410008 Hunan Peoples R China;

    Hunan Prov Clin Meditech Res Ctr Breast Canc Changsha 410008 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp Dept Pathol Changsha 410008 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp 3 Dept Pathol Changsha 410013 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp 3 Dept Pain Changsha 410013 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;

    Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    ANLN; Breast cancer; Anthracycline; Prognosis;

    机译:anln;乳腺癌;蒽环类;预后;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号